Clinical Trials Logo

Polyps of Colon clinical trials

View clinical trials related to Polyps of Colon.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05006092 Completed - Clinical trials for Artificial Intelligence

Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)

SMARTIE
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Evaluation of an artificial intelligence system for polyp detection (CADe)

NCT ID: NCT03515343 Completed - Colo-rectal Cancer Clinical Trials

Optivista : I-SCAN OE for Optical Diagnosis of Small Colon Polyps

Optivista
Start date: March 9, 2018
Phase:
Study type: Observational

This prospective randomized clinical trial aims to evaluate the new Optivista system compared to the iScan for his optical diagnosis and interval agreement monitoring with pathology. The Participants will be randomized to be diagnosed by either Optivista or Pentax iScan, and all polyps detected during the procedure, their size, location and morphology will be recorded according to the Paris classification after which all polyps will be resected per standard practices and sent for histopathologic evaluation. Further optical assessments will be performed for all polyps of 1-10 mm in size (WASP, NICE, SANO and SIMPLE classification) after with an analysis of comparison between optical diagnosis and pathology results will be performed.

NCT ID: NCT03467451 Completed - Polyps of Colon Clinical Trials

Rétrospective Evaluation of the Performance and the Safety of the Endoscopic Mucosectomy With Anchorage

Start date: July 1, 2015
Phase:
Study type: Observational

This safe and simple technique without extra cost would allow us to improve R0 resection ratio and so decrease relapses and the time between two different exams

NCT ID: NCT03346005 Completed - Colorectal Cancer Clinical Trials

Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM)

Start date: November 9, 2017
Phase: N/A
Study type: Interventional

The present study aims to investigate the diagnostic accuracy of exhaled breath analysis with the Aeonose (the eNose Company, Zutphen, the Netherlands) to distinguish the breath of patients suspected for CRC (based on a positive fecal immunochemical test), who are truly diagnosed with CRC, from patients suspected for CRC in whom this diagnosis is rejected after colonoscopy.